VeriMomVeriMom

resveratryl tris-ethylhexanoate hamilelikte güvenli mi?

No EU Annex II/III listing or harmonised CLP classification was found for this substance; no SCCS/CIR safety assessment specific to resveratryl tris‑ethylhexanoate was found. However, it is derived from resveratrol, a phytoestrogen with in vitro estrogenic activity and some reported endocrine‑related effects in the literature (resveratrol class = structural/biochemical alert), so a class/structural‑alert flag is applied (h=1). Mechanistically this is theoretical only (m=1) because the concern is based on parent resveratrol’s in vitro endocrine activity and possible metabolic release — no direct in vivo developmental/reproductive studies on this specific ester were located. Absorption from topical use is likely low but measurable (e=1) given the ester is lipophilic and intended for topical formulations; no dermal absorption data for this exact ester were found.

İçerikler
resveratryl tris-ethylhexanoate
ORTA RISK
67
/100
0

Hamilelikte resveratryl tris-ethylhexanoate yerine kullanılabilecek güvenli alternatifler | VeriMom

Related ingredients

Frequently asked questions

resveratryl tris-ethylhexanoate hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised CLP classification was found for this substance; no SCCS/CIR safety assessment specific to resveratryl tris‑ethylhexanoate was found. However, it is derived from resveratrol, a phytoestrogen with in vitro estrogenic activity and some reported endocrine‑related effects in the literature (resveratrol class = structural/biochemical alert), so a class/structural‑alert flag is applied (h=1). Mechanistically this is theoretical only (m=1) because the concern is based on parent resveratrol’s in vitro endocrine activity and possible metabolic release — no direct in vivo developmental/reproductive studies on this specific ester were located. Absorption from topical use is likely low but measurable (e=1) given the ester is lipophilic and intended for topical formulations; no dermal absorption data for this exact ester were found.
resveratryl tris-ethylhexanoate emzirirken güvenli mi?
Same justification as pregnancy: no direct reproductive/breastmilk transfer data for this specific ingredient. Because it is a resveratrol derivative, a conservative structural/class alert is applied (h=1) and mechanism remains theoretical (m=1). Exposure from topical application to the breast is expected to be low but measurable (e=1); no data were found on transfer into breastmilk for this ester.
resveratryl tris-ethylhexanoate bebek cildi için güvenli mi?
No infant‑specific safety studies for resveratryl tris‑ethylhexanoate were identified. Hazard and mechanism scores remain the same as adult (h=1, m=1) because there is no infant‑specific evidence of increased hazard or a different mechanism. Exposure score is increased by +1 (e=2) to account for higher per‑weight exposure and immature barrier in 0–3‑year‑old skin when the ingredient has measurable dermal absorption in adults.
VeriMom resveratryl tris-ethylhexanoate nasıl puanlıyor?
VeriMom resveratryl tris-ethylhexanoate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 67/100 (orta risk) olarak puanlar.
Hamilelikte resveratryl tris-ethylhexanoate yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin